180 related articles for article (PubMed ID: 34983074)
1. Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease.
Galli M; Franchi F; Rollini F; Been L; Jaoude PA; Rivas A; Zhou X; Jia S; Maaliki N; Lee CH; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Geisler T; Jennings LK; Bass TA; Angiolillo DJ
Thromb Haemost; 2022 Aug; 122(8):1341-1351. PubMed ID: 34983074
[TBL] [Abstract][Full Text] [Related]
2. Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy.
Galli M; Franchi F; Rollini F; Been L; Jaoude PA; Rivas A; Zhou X; Jia S; Maaliki N; Lee CH; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Geisler T; Jennings LK; Bass TA; Angiolillo DJ
Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):728-737. PubMed ID: 35353154
[TBL] [Abstract][Full Text] [Related]
3. Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
Ortega-Paz L; Franchi F; Rollini F; Galli M; Been L; Ghanem G; Shalhoub A; Ossi T; Rivas A; Zhou X; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Jennings LK; Angiolillo DJ
Thromb Haemost; 2024 Mar; 124(3):263-273. PubMed ID: 37224883
[TBL] [Abstract][Full Text] [Related]
4. Cigarette smoking and antiplatelet effects of aspirin monotherapy versus clopidogrel monotherapy in patients with atherosclerotic disease: results of a prospective pharmacodynamic study.
Rollini F; Franchi F; Cho JR; Degroat C; Bhatti M; Ferrante E; Patel R; Darlington A; Tello-Montoliu A; Desai B; Ferreiro J; Muniz-Lozano A; Zenni MM; Guzman LA; Bass TA; Angiolillo DJ
J Cardiovasc Transl Res; 2014 Feb; 7(1):53-63. PubMed ID: 24395495
[TBL] [Abstract][Full Text] [Related]
5. Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study.
Franchi F; Rollini F; Cho JR; King R; Phoenix F; Bhatti M; DeGroat C; Tello-Montoliu A; Zenni MM; Guzman LA; Bass TA; Ajjan RA; Angiolillo DJ
Thromb Haemost; 2016 Mar; 115(3):622-31. PubMed ID: 26633836
[TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats.
Lo ST; Li RHL; Georges CJ; Nguyen N; Chen CK; Stuhlmann C; Oldach MS; Rivas VN; Fousse S; Harris SP; Stern JA
J Vet Intern Med; 2023; 37(4):1390-1400. PubMed ID: 37208839
[TBL] [Abstract][Full Text] [Related]
7. Response to antiplatelet therapy is independent of endogenous thrombin generation potential.
Gremmel T; Panzer S; Steiner S; Seidinger D; Koppensteiner R; Pabinger I; Kopp CW; Ay C
Thromb Res; 2013 Jul; 132(1):e24-30. PubMed ID: 23623170
[TBL] [Abstract][Full Text] [Related]
8. Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel.
Puccini M; Rauch C; Jakobs K; Friebel J; Hassanein A; Landmesser U; Rauch U
Cardiovasc Drugs Ther; 2023 Aug; 37(4):833-837. PubMed ID: 35211819
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction.
Borst O; Münzer P; Alnaggar N; Geue S; Tegtmeyer R; Rath D; Droppa M; Seizer P; Heitmeier S; Heemskerk JWM; Jennings LK; Storey RF; Angiolillo DJ; Rocca B; Spronk H; Ten Cate H; Gawaz M; Geisler T
Blood Adv; 2018 Mar; 2(6):715-730. PubMed ID: 29588304
[TBL] [Abstract][Full Text] [Related]
10. Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.
Franchi F; Rollini F; Garcia E; Rivas Rios J; Rivas A; Agarwal M; Kureti M; Nagaraju D; Wali M; Briceno M; Moon JY; Kairouz V; Yaranov D; Been L; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
Thromb Haemost; 2020 Jan; 120(1):83-93. PubMed ID: 31470444
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.
Moshfegh K; Redondo M; Julmy F; Wuillemin WA; Gebauer MU; Haeberli A; Meyer BJ
J Am Coll Cardiol; 2000 Sep; 36(3):699-705. PubMed ID: 10987587
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation.
Rollini F; Tello-Montoliu A; Patel R; Darlington A; Wilson RE; Franchi F; Muñiz-Lozano A; Desai B; Bender N; Sakariassen KS; Angiolillo DJ
J Thromb Thrombolysis; 2014; 37(2):131-8. PubMed ID: 23943337
[TBL] [Abstract][Full Text] [Related]
13. Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications.
Galli M; Franchi F; Rollini F; Ortega-Paz L; D'Amario D; De Caterina R; Mehran R; Gibson CM; Angiolillo DJ
Expert Rev Clin Pharmacol; 2023 Jan; 16(1):27-38. PubMed ID: 36455906
[TBL] [Abstract][Full Text] [Related]
14. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
[TBL] [Abstract][Full Text] [Related]
15. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
[TBL] [Abstract][Full Text] [Related]
16. Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study.
Duthoit G; Silvain J; Marijon E; Ducrocq G; Lepillier A; Frere C; Dimby SF; Popovic B; Lellouche N; Martin-Toutain I; Spaulding C; Brochet E; Attias D; Mansourati J; Lorgis L; Klug D; Zannad N; Hauguel-Moreau M; Braik N; Deltour S; Ceccaldi A; Wang H; Hammoudi N; Brugier D; Vicaut E; Juliard JM; Montalescot G
Circ Cardiovasc Interv; 2020 Jul; 13(7):e008481. PubMed ID: 32674675
[TBL] [Abstract][Full Text] [Related]
17. Both G protein-coupled and immunoreceptor tyrosine-based activation motif receptors mediate venous thrombosis in mice.
Mwiza JMN; Lee RH; Paul DS; Holle LA; Cooley BC; Nieswandt B; Schug WJ; Kawano T; Mackman N; Wolberg AS; Bergmeier W
Blood; 2022 May; 139(21):3194-3203. PubMed ID: 35358299
[TBL] [Abstract][Full Text] [Related]
18. [Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].
Morel O; Viellard C; Faure A; Jesel L; Ohlmann P; Desprez D; Chauvin M; Roul G; Grunebaum L; Bareiss P
Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):21-9. PubMed ID: 17343035
[TBL] [Abstract][Full Text] [Related]
19. Differential Inhibition of Platelet Reactivity by Dual Therapy With Aspirin and Low-Dose Rivaroxaban in Peripheral Arterial Disease: A Pilot Study.
Jurk K; Rothenaicher KF; Groß K; Rossmann H; Weißer G; Schmidtmann I; Münzel T; Espinola-Klein C
Front Cardiovasc Med; 2022; 9():865166. PubMed ID: 35600474
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study.
Franchi F; Rollini F; Kairouz V; Rivas Rios J; Rivas A; Agarwal M; Briceno M; Wali M; Nawaz A; Silva G; Shaikh Z; Maaliki N; Been L; Piraino J; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Jennings LK; Bass TA; Angiolillo DJ
JACC Basic Transl Sci; 2019 Nov; 4(7):763-775. PubMed ID: 31998847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
